Ganymed Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference

News   Dec 26, 2013

 
Ganymed Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
 
 
 
 

RELATED ARTICLES

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

New Way Found to Boost Immunity in Fighting Cancer and Infections

News

Researchers have identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and cancer.

READ MORE

Enterome and Nestlé Health Sciences Launch New Diagnostics Company

News

Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE